Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MIMEDX GROUP, INC. Director's Dealing 2025

Nov 10, 2025

32206_dirs_2025-11-10_1d5deeae-2973-4d3f-8607-49929b73df54.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2025-11-06

Reporting Person: Maersk-Moller Kimberly (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-06 Common Stock S 58300 $7.4156 Disposed 236982 Direct

Footnotes

F1: The price indicated is a weighted average price. The corresponding shares were sold in multiple transactions. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.